Jordan Cloyd
OHIO STATE UNIVERSITY
Appearances
- DateMay 9, 2023SOCIETY: SSAT
Moderators
Indiana University School of MedicineOHIO STATE UNIVERSITYHumanitas Mirasole SpA - DateMay 9, 2023BACKGROUND: The majority of HCC patients within Milan criteria, compete with cirrhosis patients with high MELD for liver transplantation based on an exceptional score which is the calculated MELD at registration, 28 after six months of waiting, 31 after 1 year and thereafter capped at 34 after one…
Presenter
Speakers
The Ohio State Wexner Medical CenterOHIO STATE UNIVERSITY - DateMay 9, 2023BACKGROUND: The majority of HCC patients within Milan criteria, compete with cirrhosis patients with high MELD for liver transplantation based on an exceptional score which is the calculated MELD at registration, 28 after six months of waiting, 31 after 1 year and thereafter capped at 34 after one…
Presenter
Speakers
OHIO STATE UNIVERSITYThe Ohio State Wexner Medical Center - DateMay 9, 2023Pancreatic ductal adenocarcinoma (PDAC) exists in several morphological subtypes differing in prognostic significance. However, to date, a clinico-morphological correlation of these subtypes in the context of neoadjuvant therapy (NAT) has not been performed…
Presenter
Speakers
The Ohio State Wexner Medical CenterOHIO STATE UNIVERSITY - DateMay 9, 2023BACKGROUND: To address the persistent ethnoracial and socioeconomic disparities in access to quality surgical cancer care, it is imperative to rigorously understand the role of clinician-level factors including clinician-to-clinician connectedness…
Presenter
Speakers
OHIO STATE UNIVERSITYThe Ohio State Wexner Medical Center - DateMay 9, 2023BACKGROUND: To address the persistent ethnoracial and socioeconomic disparities in access to quality surgical cancer care, it is imperative to rigorously understand the role of clinician-level factors including clinician-to-clinician connectedness…
Presenter
Speakers
OHIO STATE UNIVERSITYThe Ohio State Wexner Medical Center - DateMay 21, 2024This panel is a debate session that will be presented through video highlights and instruction on the benefits of various techniques used in hepatobiliary and pancreas surgery…
Moderators
OHIO STATE UNIVERSITYStanford UniversityUniversidad de Buenos Aires - DateMay 21, 2024Objectives: Neoadjuvant therapy (NT) is increasingly utilized prior to surgery for most gastrointestinal (GI) and hepatopancreatobiliary (HPB) malignancies. However, chemotherapy and radiation therapy can cause significant symptoms and a high incidence of adverse events…
Presenter
Speakers
The Ohio State Wexner Medical CenterOHIO STATE UNIVERSITY